CUSPIDI, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 38.902
EU - Europa 10.854
AS - Asia 5.946
SA - Sud America 76
AF - Africa 41
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 16
Totale 55.864
Nazione #
US - Stati Uniti d'America 38.362
CN - Cina 2.090
IE - Irlanda 1.972
SG - Singapore 1.888
RU - Federazione Russa 1.792
IT - Italia 1.647
UA - Ucraina 1.519
SE - Svezia 1.482
HK - Hong Kong 1.217
DE - Germania 808
GB - Regno Unito 684
CA - Canada 513
FI - Finlandia 380
VN - Vietnam 272
FR - Francia 204
ID - Indonesia 136
TR - Turchia 136
NL - Olanda 83
IN - India 78
DK - Danimarca 74
BR - Brasile 54
AT - Austria 42
BE - Belgio 36
JP - Giappone 36
CZ - Repubblica Ceca 23
MX - Messico 23
AU - Australia 20
IR - Iran 17
PL - Polonia 14
ES - Italia 13
MY - Malesia 12
RO - Romania 12
BG - Bulgaria 11
EU - Europa 11
KR - Corea 11
AR - Argentina 9
NZ - Nuova Zelanda 9
CL - Cile 8
GR - Grecia 8
NG - Nigeria 8
SK - Slovacchia (Repubblica Slovacca) 8
TH - Thailandia 8
HU - Ungheria 7
PT - Portogallo 6
RS - Serbia 6
TW - Taiwan 6
ZA - Sudafrica 6
A2 - ???statistics.table.value.countryCode.A2??? 5
EG - Egitto 5
NO - Norvegia 5
BD - Bangladesh 4
CH - Svizzera 4
IL - Israele 4
LK - Sri Lanka 4
MU - Mauritius 4
PH - Filippine 4
TN - Tunisia 4
KE - Kenya 3
KG - Kirghizistan 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
CO - Colombia 2
GE - Georgia 2
GH - Ghana 2
IQ - Iraq 2
TT - Trinidad e Tobago 2
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
TG - Togo 1
UG - Uganda 1
Totale 55.864
Città #
Ann Arbor 7.832
Woodbridge 4.349
Fairfield 4.239
Houston 3.080
Ashburn 1.909
Dublin 1.859
Jacksonville 1.804
Wilmington 1.791
Seattle 1.614
Singapore 1.546
Cambridge 1.397
Dearborn 1.360
Chandler 1.355
Hong Kong 1.201
Princeton 999
New York 810
Milan 632
Frankfurt am Main 544
Santa Clara 520
Lawrence 478
Altamura 453
Nanjing 414
Beijing 310
Lachine 309
San Diego 302
Dong Ket 171
Nanchang 143
Shenyang 141
Andover 139
Jakarta 127
Hebei 120
Shanghai 120
Guangzhou 102
Falls Church 93
Ottawa 89
Norwalk 87
Jiaxing 78
Toronto 78
London 77
Tianjin 74
Boardman 70
Changsha 65
Jinan 60
Los Angeles 55
Helsinki 51
Detroit 48
Kunming 42
Vienna 37
Washington 37
Ningbo 36
San Mateo 36
Zhengzhou 35
Lissone 33
Brussels 32
Hangzhou 31
Huizen 31
Mountain View 31
Fremont 30
Redmond 27
Hefei 25
Rome 24
Dallas 22
Philadelphia 21
Esslingen am Neckar 20
Hounslow 20
Taizhou 19
Groningen 18
Chicago 15
Edmonton 15
Fuzhou 15
Kilburn 14
Lappeenranta 14
Loreto 14
Phoenix 13
Pune 13
São Paulo 13
Brno 12
Chengdu 12
Busto Arsizio 11
Frontone 11
Munich 11
Taiyuan 11
University Park 11
Bologna 10
Edinburgh 10
New Bedfont 10
San Francisco 10
Tappahannock 10
Carate Brianza 9
Central 9
Hanoi 9
Islington 9
Moscow 9
Prescot 9
Zapopan 9
Auburn Hills 8
Lanzhou 8
Laurel 8
Leawood 8
Monmouth Junction 8
Totale 44.060
Nome #
Reproducibility of dipping/nondipping pattern in untreated essential hypertensive patients: impact of sex and age 293
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 288
Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension 269
Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects 266
Effects of different sodium intakes on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients 259
Cardiopulmonary receptor regulation of renin release 257
Antihypertensive and water and sodium balance effects of felodipine, a new vasodilating calcium antagonist, in hypertensive patients 253
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 253
The development of new antihypertensive drugs with specific properties for the treatment of established hypertension 251
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 241
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 231
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone 227
Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method 226
Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients 224
Renal and antihypertensive effects of felodipine in hypertensive patients 216
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 212
Effects of moderate low sodium/high potassium diet on essential hypertension: results of a comparative study 207
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials 204
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 201
[Pseudo-Conn's syndrome after habitual ingestion of liquorice. Report on various clinical cases] 199
Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? 197
Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients 192
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 192
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 190
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 190
Clinical evaluation of a new antihypertensive drug (Indapamide) 189
Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice 187
Treatment of hypertension: The ESH/ESC guidelines recommendations 186
Correlation between arterial pressure at rest and during effort and left ventricular mass in hypertensive patients who were never treated 186
Hemodynamic, humoral and renal effects of the acute administration of nifedipine in hypertensive patients 185
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 185
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 183
The association between 24-h blood pressure patterns and left ventricular mechanics 177
Blood pressure control in hypertension. Pros and cons of available treatment strategies 175
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 174
Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives 173
Left ventricular geometry and diastolic function in the hypertensive heart: impact of age. 173
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 173
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 173
Left atrial function in elite athletes: A meta-analysis of two-dimensional speckle tracking echocardiographic studies 173
Ambulatory heart rate and target organ damage in never-treated essential hypertensives 172
How reliable is isolated clinical hypertension defined by a single 24-h ambulatory blood pressure monitoring? 171
Neurogenic abnormalities in masked hypertension 171
Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue Doppler study in echocardiographic practice 170
Incident Left Ventricular Hypertrophy in Masked Hypertension 170
Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? 168
How does blood pressure change in hypertensive patients with atrial fibrillation after successful electrical cardioversion? 167
Metabolic syndrome and multiple organ damage in essential hypertension 165
Obesity and heart failure with preserved ejection fraction: a paradox or something else? 165
Aortic root dilatation in hypertensive patients: A multicenter survey in echocardiographic practice 164
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 163
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 162
Subclinical hyperthyroidism and biatrial function and mechanics: a two- and three-dimensional echocardiographic study 161
Metabolic syndrome and target organ damage: Role of blood pressure 159
Self-Reported Weight and Height: Implications for Left Ventricular Hypertrophy Detection. An Italian Multi-Center Study 159
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 159
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 159
Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice 158
Effects of long-term lercanidipine or hydrochlorothiazide administration on hypertension-related vascular structural changes 155
Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: Results from the Assessment Prognostic Risk Observational Survey (APROS) 154
Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus. 154
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 153
How does subclinical hyperthyroidism affect right heart function and mechanics? 153
Prevalence and correlates of multiple organ damage in referred treated hypertensives: Data from the ETODH study 152
Right ventricular mechanics in patients with aortic stenosis and preserved ejection fraction: Is arterial hypertension a new player in the game? 152
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness 151
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 151
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 151
Management of hypertension in patients with left ventricular hypertrophy 150
Indexation of left ventricular mass to body surface area and height to allometric power of 2,7: is the difference limited to obese hypertensives? 150
Is blunted heart rate decrease at night associated with prevalent organ damage in essential hypertension? 150
Extreme dipping: Always means nocturnal hypotension? 149
Effects of the metabolic syndrome on right heart mechanics and function. 148
Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients 148
Is the blunted fall in nighttime heart rate a marker of subclinical cardiac damage? 148
The impact of different left ventricular geometric patterns on right ventricular deformation and function in hypertensive patients 147
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 147
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 146
Is fetuin-A a biomarker of preclinical atherosclerosis in essential hypertension? 146
The Impact of White-Coat Hypertension on Cardiac Mechanics 146
Home and ambulatory blood pressure in resistant hypertension 145
Cardiac and carotid structure in patients with established hypertension and white-coat hypertension 145
New-onset left atrial enlargement in a general population 145
Intriguing relationship between antihypertensive therapy and cancer 145
Metabolic syndrome and biventricular hypertrophy in essential hypertension 145
Nocturnal blood pressure in untreated essential hypertensives 144
Heart and Prehypertension 144
The Hyper-Pract Study: A multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice 143
Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure 143
Nocturnal hypertension and organ damage in dippers and nondippers 143
Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis 143
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 143
The relationship between functional capacity and left ventricular strain in patients with uncomplicated type 2 diabetes 143
Left ventricular hypertrophy and abdominal aorta size in essential hypertension 142
Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study. 142
Masked hypertension: an independent predictor of organ damage 142
Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study 141
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 141
Phasic Left Atrial Function in Cancer Patients Before Initiation of Anti-Cancer Therapy. 141
Do reverse dippers have the highest risk of right ventricular remodeling? 141
Totale 17.555
Categoria #
all - tutte 212.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 212.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.131 0 0 0 0 0 1.421 1.438 860 1.059 439 646 268
2020/20219.462 546 504 811 1.000 621 919 1.068 1.097 773 949 401 773
2021/20226.263 472 536 887 442 392 367 359 406 415 380 515 1.092
2022/20236.265 1.083 1.784 392 399 364 1.078 83 304 400 69 211 98
2023/20245.314 142 111 112 187 915 1.377 963 84 741 105 57 520
2024/20255.680 921 1.945 411 669 1.380 354 0 0 0 0 0 0
Totale 57.908